GLP-1 Dossier

The record → All 128 providers → MEDVi

Provider Dossier · medvi.com · Last verified 28 October 2026

Is MEDVi legit?

Quick answerLast verified · GLP-1 Dossier Editorial Desk

Our enforcement sweep matched 1 primary-sourced regulatory or legal action on file involving MEDVi (medvi.com), each linked to the original document below.

Published prices start at $299/mo, with medication included.

It supplies compounded GLP-1 medication, which is not FDA-approved.

Visit MEDVi (medvi.com) →

Disclosure: Unmonetized direct link (MEDVi has no commercial relationship with this site).

Editorial Desk SummaryFile ID: MEDVI

Yes, MEDVi (medvi.com) is a real, operating US telehealth company that ships prescriptions, not a counterfeit card-skimming site. However, our enforcement sweep matched 1 primary-sourced regulatory or legal action on file involving the company, each linked to the original government or court document below.

On the clinical side, MEDVi prescribes compounded GLP-1 medication only (prepared by a compounding pharmacy rather than an FDA-approved manufacturer), and its published plan starts at $179 for the first month before renewing at $299/mo (medication included).

Before You Sign Up · 3 Checkout & Contract Terms to Verify
1. Monthly Rate StructureAll-in (medication included)$299/mo published base rate
2. First-Month vs. Renewal$179 mo 1 → $299/moCheck auto-renewal notice window in terms
3. Dose Tier & PharmacyCompounded onlyConfirm 503A/503B pharmacy on vial
Before You Commit · Zero-Action Same-Category LedgerOrdered by published monthly price · 0 actions on file

Comparing MEDVi against compounded only providers with 0 actions on file

MEDVi has 1 regulatory or legal action documented below. For readers comparing transparent options in the same supply category before entering payment details, these providers have 0 actions on file and published monthly pricing:

Embodyjoinem.co
All-in (medication included) · 0 actions on file · Pharmacy: Red Rock Pharmacy, Precision Compounding Pharmacy
$49/mo$49 first month
SnagRxsnagrx.com
All-in (medication included) · 0 actions on file · Pharmacy: Red Rock Pharmacy, Precision Compounding Pharmacy
$69/moongoing rate
Bodybuilding Health+bbhealthplus.com
All-in (medication included) · 0 actions on file · Pharmacy: Strive Pharmacy, Epiq Scripts
$141.50/mo$179 first month
Amble Healthjoinamble.com
All-in (medication included) · 0 actions on file · Pharmacy: Red Rock Pharmacy, Strive Pharmacy
$179/mo$135 first month
Dossier Verification Log · What We CheckedSweep date: 16 November 2026
Website & Terms inspected
medvi.com (Public pricing & disclosures reviewed)
Last price & terms read
16 November 2026 (Medication included in quoted monthly rate)
503A / 503B pharmacy disclosure
No partner compounding pharmacy named upfront before intake
Public registries searched
FDA CDER Warning Letters (2024–2026), Federal District Court Dockets (PACER / CourtListener), FTC Enforcement Actions, NAD Case Reports → 1 primary document linked below
Researcher field note
Operated by MEDVi, LLC d/b/a MEDVi (medvi.com). Compounded semaglutide is $179 for the first month then $299/month for ongoing refills, and compounded tirzepatide is $299/month flat, with asynchronous consultation and shipping bundled. Received an FDA Warning Letter (MARCS-CMS 721455) on 20 February 2026 alleging its compounded semaglutide and tirzepatide pages carried MEDVi-branded vial labels that falsely implied MEDVi was the compounder and made unapproved equivalence claims to Wegovy and Ozempic.
Websitemedvi.com
SuppliesCompounded only
From$299/mo
Promo / bundle$179
MedicationIncluded
InsuranceCash pay
IntakeAsync
On file1 action

What it actually supplies

Supplies compounded semaglutide or tirzepatide: medication prepared by a compounding pharmacy rather than an FDA-approved product. Cheaper, legal, and the category the FDA has been issuing warning letters about since September 2025.

Named on its own site (medvi.com): compounded semaglutide, compounded tirzepatide.

What regulators and courts have said

Every entry below links to its original document and identifies the source type. We publish what the official record states and nothing beyond it; a regulatory letter or lawsuit involving a company is not proof that an individual patient was harmed.

February 2026

FDA warning letter to MEDVi, LLC dba MEDVi (MARCS-CMS 721455) alleging the products carried MEDVi branding that falsely suggested MEDVi was the compounder, that claims such as 'same active ingredient as Wegovy and Ozempic' implied FDA approval, and that the products were misbranded under FD&C Act sections 502(a) and 502(bb), with seizure, injunction and border detention warned as possible consequences.

Inspect primary document →

Corporate entity, pricing & cancellation terms

Operated by MEDVi, LLC d/b/a MEDVi (medvi.com). Compounded semaglutide is $179 for the first month then $299/month for ongoing refills, and compounded tirzepatide is $299/month flat, with asynchronous consultation and shipping bundled. Received an FDA Warning Letter (MARCS-CMS 721455) on 20 February 2026 alleging its compounded semaglutide and tirzepatide pages carried MEDVi-branded vial labels that falsely implied MEDVi was the compounder and made unapproved equivalence claims to Wegovy and Ozempic.

Go direct

The button below is a plain direct link to MEDVi and earns us nothing. MEDVi has no commercial arrangement with this desk and is documented under the exact same verification rules as companies that do pay.

Visit MEDVi (medvi.com) →

Lower advertised starting prices

Providers advertising a lower monthly entry figure. Check each dossier before comparing two numbers: the headline price alone does not tell you whether medication is included.

PlushCareFDA-approved

From $19.99/mo

EmbodyCompounded

From $49/mo

Lemonaid HealthBoth

From $49/mo

If you prefer FDA-approved medication only

These clinics prescribe FDA-approved brand-name drugs only and currently have 0 regulatory actions on file here.

CalibrateFDA-approved

From $199/mo

Everlywell (Weight Care+)FDA-approved

Price not published

Form HealthFDA-approved

From $299/mo

GoodLife HealthFDA-approved

From $299/mo

Side-by-side records

Compared with the alternatives

Direct dossier comparisons for the providers patients most frequently weigh against MEDVi.

Looking to switch providers? Alternatives to MEDVi orders every clinic in the same supply category by published monthly cost and regulatory record.
Henry Meds vs MEDViCompoundedCompounded

$179 vs $299 / mo

Compare both dossiers →
Strut Health vs MEDViCompoundedCompounded

$99 vs $299 / mo

Compare both dossiers →

Long-form provider files

Full price tables, terms and records

Every plan length, the refund and cancellation terms, named pharmacies, review-site links and each regulatory action with its primary document. These 6 providers pay us a referral commission if you sign up through our links; ordered by lowest verified monthly price only.

Provider fileSema. /moTirz. /moActions on fileLinks
Embody$49$99NoneRead the dossier →Embody site ↗
Belle$93$1491Read the dossier →Belle site ↗
PlexusDx$99$129NoneRead the dossier →PlexusDx site ↗
MEDGm$169$269NoneRead the dossier →MEDGm site ↗
DirectMeds$249$3991Read the dossier →DirectMeds site ↗
GoodLife Health$299 membership+ brand-name drugNoneRead the dossier →GoodLife Health site ↗

Each row has two links: “Read the dossier” opens our file on that provider, and the “site ↗” button opens the provider’s own site in a new tab. Nothing else in the row is a link. Where a provider runs an affiliate programme with us, its site button is a referral link and we may earn a commission at no cost to you. It never changes the order or what is on file.

Reference notes

MEDVi: key questions answered

Is MEDVi (medvi.com) legit or a scam? What does the public record show?
Yes. MEDVi (medvi.com) is an active, operating US weight-loss telehealth company. It supplies compounded semaglutide or tirzepatide prepared by a state-licensed compounding pharmacy rather than an FDA-approved brand-name drug. Our regulatory sweep matched 1 primary-sourced regulatory or legal action on file: FDA warning letter to MEDVi, LLC dba MEDVi (MARCS-CMS 721455) alleging the products carried MEDVi branding that falsely suggested MEDVi was the compounder, that claims such as 'same active ingredient as Wegovy and Ozempic' implied FDA approval, and that the products were misbranded under FD&C Act sections 502(a) and 502(bb), with seizure, injunction and border detention warned as possible consequences.
Does MEDVi sell compounded or FDA-approved weight loss medication?
Compounded only. Supplies compounded semaglutide or tirzepatide: medication prepared by a compounding pharmacy rather than an FDA-approved product. Cheaper, legal, and the category the FDA has been issuing warning letters about since September 2025. Specifically named on medvi.com: compounded semaglutide, compounded tirzepatide.
What are MEDVi weight loss pricing, hidden fees, and cancellation terms?
MEDVi (medvi.com) publishes weight-loss plans starting at $299 per month, with medication included in that monthly figure, alongside a promotional or bundle rate of $179. Operated by MEDVi, LLC d/b/a MEDVi (medvi.com). Compounded semaglutide is $179 for the first month then $299/month for ongoing refills, and compounded tirzepatide is $299/month flat, with asynchronous consultation and shipping bundled. Received an FDA Warning Letter (MARCS-CMS 721455) on 20 February 2026 alleging its compounded semaglutide and tirzepatide pages carried MEDVi-branded vial labels that falsely implied MEDVi was the compounder and made unapproved equivalence claims to Wegovy and Ozempic.
What compounding or fulfillment pharmacy does MEDVi use?
MEDVi (medvi.com) states that compounded GLP-1 prescriptions are fulfilled through state-licensed 503A or 503B compounding pharmacies, without listing specific partner pharmacy names on its public pre-checkout pages. Patients can verify the exact compounding pharmacy, address, and state board license number printed on the prescription vial label upon delivery.
Are there FDA warning letters, lawsuits, or regulatory complaints against MEDVi?
Yes. We hold 1 primary-sourced regulatory or legal action on record involving MEDVi (medvi.com): FDA warning letter to MEDVi, LLC dba MEDVi (MARCS-CMS 721455) alleging the products carried MEDVi branding that falsely suggested MEDVi was the compounder, that claims such as 'same active ingredient as Wegovy and Ozempic' implied FDA approval, and that the products were misbranded under FD&C Act sections 502(a) and 502(bb), with seizure, injunction and border detention warned as possible consequences. Every entry links directly to the primary FDA, NAD, or court document on this page.
Cite This Dossier · Open Public Record & Machine-Readable Feeds
Source: GLP-1 Dossier Editorial Desk (2026), “Is MEDVi Legit? Pricing, 503A/503B Pharmacies & Regulatory Record,” https://glp1dossier.com/is-medvi-legit (Verified 16 November 2026).